Skip to main content
. 2023 Mar 17;23:267. doi: 10.1186/s12913-023-09263-4

Table 4.

Market share of prophylactic uterotonics under current and new environment (2022–2026)

Intervention 2022 2023 2024 2025 2026
Current Environment (without Heat-Stable Carbetocin)
 Oxytocin 80% 80% 80% 80% 80%
 Misoprostol 20% 20% 20% 20% 20%
New Environment (with Heat-Stable Carbetocin)
 Heat-stable carbetocin 0.2% 2% 6% 13% 19%
 Oxytocin 79.8% 78% 75% 69% 63%
 Misoprostol 20% 20% 19% 18% 18%